GTS5:Volunteer Assignments and Opportunities: Difference between revisions
| [checked revision] | [checked revision] |
No edit summary |
No edit summary |
||
| Line 159: | Line 159: | ||
| | | | ||
| | | | ||
|Named based on GTS5 book Template added | |Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO PEDS5, CNS5. | ||
|- | |- | ||
|[[GTS5:Costello_syndrome_(HRAS)|Costello syndrome (HRAS)]] | |[[GTS5:Costello_syndrome_(HRAS)|Costello syndrome (HRAS)]] | ||
| Line 203: | Line 203: | ||
| | | | ||
| | | | ||
|Named based on GTS5 book Template added | |Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO FEMA5, THOR5, MALE5, CNS5, ENDO5, SKIN5. | ||
|- | |- | ||
|[[GTS5:PROS_syndrome_(PIK3CA)|PROS syndrome (PIK3CA)]] | |[[GTS5:PROS_syndrome_(PIK3CA)|PROS syndrome (PIK3CA)]] | ||
| Line 293: | Line 293: | ||
|Eric McGinnis | |Eric McGinnis | ||
| | | | ||
|Named based on GTS5 book ( | |Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO PEDS5. | ||
|- | |- | ||
|[[GTS5:Multiple_endocrine_neoplasia_type_1_(MEN1)|Multiple endocrine neoplasia type 1 (MEN1)]] | |[[GTS5:Multiple_endocrine_neoplasia_type_1_(MEN1)|Multiple endocrine neoplasia type 1 (MEN1)]] | ||
| Line 304: | Line 304: | ||
|Eric McGinnis | |Eric McGinnis | ||
| | | | ||
|Named based on GTS5 book Template added | |Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO ENDO5. | ||
|- | |- | ||
|[[GTS5:Peutz-Jeghers_syndrome_(STK11)|Peutz-Jeghers syndrome (STK11)]] | |[[GTS5:Peutz-Jeghers_syndrome_(STK11)|Peutz-Jeghers syndrome (STK11)]] | ||
| Line 315: | Line 315: | ||
|Eric McGinnis | |Eric McGinnis | ||
| | | | ||
|Named based on GTS5 book ( | |Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO MALE5, FEMA5, BRST5, DIG5. | ||
|- | |- | ||
|[[GTS5:Hereditary_gastric_and_breast_cancer_syndrome_(CDH1,_CTNNA1)|Hereditary gastric and breast cancer syndrome (CDH1, CTNNA1)]] | |[[GTS5:Hereditary_gastric_and_breast_cancer_syndrome_(CDH1,_CTNNA1)|Hereditary gastric and breast cancer syndrome (CDH1, CTNNA1)]] | ||
| Line 326: | Line 326: | ||
| | | | ||
| | | | ||
|Named based on GTS5 book ( | |Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO BRST5. | ||
|- | |- | ||
|[[GTS5:Hereditary_mixed_polyposis_syndrome_(GREM1)|Hereditary mixed polyposis syndrome (GREM1)]] | |[[GTS5:Hereditary_mixed_polyposis_syndrome_(GREM1)|Hereditary mixed polyposis syndrome (GREM1)]] | ||
| Line 348: | Line 348: | ||
| | | | ||
| | | | ||
|Named based on GTS5 book ( | |Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO CNS5, SKIN5, PEDS5, HAN5. | ||
|- | |- | ||
|[[GTS5:SMO-related_Curry-Jones_syndrome_(SMO)|SMO-related Curry-Jones syndrome (SMO)]] | |[[GTS5:SMO-related_Curry-Jones_syndrome_(SMO)|SMO-related Curry-Jones syndrome (SMO)]] | ||
| Line 370: | Line 370: | ||
| | | | ||
| | | | ||
|Named based on GTS5 book ( | |Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO CNS5. | ||
|- | |- | ||
|[[GTS5:Osteochondromatosis_(EXT1,_EXT2)|Osteochondromatosis (EXT1, EXT2)]] | |[[GTS5:Osteochondromatosis_(EXT1,_EXT2)|Osteochondromatosis (EXT1, EXT2)]] | ||
| Line 403: | Line 403: | ||
| | | | ||
| | | | ||
|Named based on GTS5 book ( | |Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO SKIN5, HAN5. | ||
|- | |- | ||
|[[GTS5:Tuberous_sclerosis_(TSC1,_TSC1)|Tuberous sclerosis (TSC1, TSC1)]] | |[[GTS5:Tuberous_sclerosis_(TSC1,_TSC1)|Tuberous sclerosis (TSC1, TSC1)]] | ||
| Line 414: | Line 414: | ||
| | | | ||
| | | | ||
|Named based on GTS5 book Template added | |Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO MALE5, CNS5, PEDS5, HAN5. | ||
|- | |- | ||
|[[GTS5:PTEN_hamartoma_tumour_syndrome_(PTEN)|PTEN hamartoma tumour syndrome (PTEN)]] | |[[GTS5:PTEN_hamartoma_tumour_syndrome_(PTEN)|PTEN hamartoma tumour syndrome (PTEN)]] | ||
| Line 425: | Line 425: | ||
|Eric McGinnis | |Eric McGinnis | ||
| | | | ||
|Named based on GTS5 book Template added | |Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO HAN5, CNS5, FEMA5, BRST5. | ||
|- | |- | ||
|[[GTS5:Activated_Phosphatidylinositol-3-OH_kinase_δ_Syndrome_-_APDS_(PIK3CD)|Activated Phosphatidylinositol-3-OH kinase δ Syndrome - APDS (PIK3CD)]] | |[[GTS5:Activated_Phosphatidylinositol-3-OH_kinase_δ_Syndrome_-_APDS_(PIK3CD)|Activated Phosphatidylinositol-3-OH kinase δ Syndrome - APDS (PIK3CD)]] | ||
| Line 447: | Line 447: | ||
| | | | ||
| | | | ||
|Named based on GTS5 book Template added | |Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO ENDO5. | ||
|- | |- | ||
|[[GTS5:MAFA-related_familial_insulinomatosis_(MAFA)|MAFA-related familial insulinomatosis (MAFA)]] | |[[GTS5:MAFA-related_familial_insulinomatosis_(MAFA)|MAFA-related familial insulinomatosis (MAFA)]] | ||
| Line 458: | Line 458: | ||
| | | | ||
| | | | ||
|Named based on GTS5 book Template added | |Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO ENDO5. | ||
|- | |- | ||
|[[GTS5:Birt-Hogg-Dube_syndrome_(FLCN)|Birt-Hogg-Dube syndrome (FLCN)]] | |[[GTS5:Birt-Hogg-Dube_syndrome_(FLCN)|Birt-Hogg-Dube syndrome (FLCN)]] | ||
| Line 469: | Line 469: | ||
| | | | ||
| | | | ||
|Named based on GTS5 book Template added | |Named based on GTS5 book GTS-Specific Template (11-7-24) added 12/29/24. Also, content in online WHO MALE5. | ||
|- | |- | ||
|[[GTS5:Familial_chordoma_(TBXT)|Familial chordoma (TBXT)]] | |[[GTS5:Familial_chordoma_(TBXT)|Familial chordoma (TBXT)]] | ||